{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:17:53Z","timestamp":1767989873600,"version":"3.49.0"},"reference-count":29,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.3892\/etm.2011.286","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T17:35:17Z","timestamp":1308332117000},"page":"887-891","source":"Crossref","is-referenced-by-count":39,"title":["Serum cytokine profiles in patients with prostate carcinoma"],"prefix":"10.3892","volume":"2","author":[{"given":"ERI","family":"TAZAKI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NOBUAKI","family":"SHIMIZU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RYOTA","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAKAZU","family":"YOSHIZUMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROSHI","family":"KAMMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHIGERU","family":"IMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOYUKI","family":"GOYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KUNIHISA","family":"KOZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ATSUYOSHI","family":"NISHINA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROKAZU","family":"KIMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2011,6,16]]},"reference":[{"key":"key20180108122608_b1-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MOU.0b013e3280eb110f","article-title":"Prostate cancer prevention","volume":"17","author":"Nelson","year":"2007","journal-title":"Curr Opin Urol"},{"key":"key20180108122608_b2-etm-02-05-0887","volume-title":"Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs; World Health Organization Classification of Tumours","author":"Eble","year":"2004"},{"key":"key20180108122608_b3-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol"},{"key":"key20180108122608_b4-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/1098-1128(200101)21:1<83::AID-MED4>3.0.CO;2-1","article-title":"Cancer cachexia: a therapeutic approach","volume":"1","author":"Argil\u00e9s","year":"2001","journal-title":"Med Res Rev"},{"key":"key20180108122608_b5-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","article-title":"Biology of cachexia","volume":"89","author":"Tisdale","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"key20180108122608_b6-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s005200050282","article-title":"Cachexia and anorexia: cancer\u2019s covert killer","volume":"8","author":"Davis","year":"2000","journal-title":"Support Care Cancer"},{"key":"key20180108122608_b7-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2370.2004.00462.x","article-title":"Cytokine gene polymorphisms and breast cancer susceptibility and prognosis","volume":"31","author":"Smith","year":"2004","journal-title":"Eur J Immunogenet"},{"key":"key20180108122608_b8-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr1648","article-title":"Oestrogen receptor-negative breast cancers exhibit high cytokine content","volume":"9","author":"Chavey","year":"2007","journal-title":"Breast Cancer Res"},{"key":"key20180108122608_b9-etm-02-05-0887","first-page":"581","article-title":"IL-6 and IFN-gamma regulation of IL-10 production by human colon carcinoma cells","volume":"18","author":"Suzuki","year":"2001","journal-title":"Int J Oncol"},{"key":"key20180108122608_b10-etm-02-05-0887","first-page":"5005","article-title":"Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer","volume":"29","author":"Szaflarska","year":"2009","journal-title":"Anticancer Res"},{"key":"key20180108122608_b11-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2006.09.039","article-title":"Interleukin 6 is associated with cachexia in patients with prostate cancer","volume":"69","author":"Kuroda","year":"2007","journal-title":"Urology"},{"key":"key20180108122608_b12-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00075197-199805000-00003","article-title":"New cachexic factors","volume":"3","author":"Tisdale","year":"1998","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"key20180108122608_b13-etm-02-05-0887","first-page":"1743","article-title":"Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer","volume":"7","author":"Nakashima","year":"1998","journal-title":"Clin Cancer Res"},{"key":"key20180108122608_b14-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/cncr.11178","article-title":"Elevation of cytokine levels in cachectic patients with prostate carcinoma","volume":"97","author":"Pfitzenmaier","year":"2003","journal-title":"Cancer"},{"key":"key20180108122608_b15-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1097-0045(20000901)44:4<271::AID-PROS2>3.0.CO;2-G","article-title":"Analysis of type T1 and T2 cytokines in patients with prostate cancer","volume":"44","author":"Filella","year":"2000","journal-title":"Prostate"},{"key":"key20180108122608_b16-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.bjc.6600855","article-title":"A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells","volume":"88","author":"Wang","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180108122608_b17-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1677\/ERC-09-0109","article-title":"Emerging roles of chemokines in prostate cancer","volume":"3","author":"Vindrieux","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"key20180108122608_b18-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0002-9440(10)63067-2","article-title":"Interleukin-6 is an autocrine growth factor in human prostate cancer","volume":"159","author":"Giri","year":"2001","journal-title":"Am J Pathol"},{"key":"key20180108122608_b19-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cdp.2008.02.007","article-title":"Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer","volume":"32","author":"Bouraoui","year":"2008","journal-title":"Cancer Detect Prev"},{"key":"key20180108122608_b20-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"key":"key20180108122608_b21-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1172\/JCI36130","article-title":"The cytokine network in asthma and chronic obstructive pulmonary disease","volume":"118","author":"Barnes","year":"2008","journal-title":"J Clin Invest"},{"key":"key20180108122608_b22-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.neo.7900124","article-title":"Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice","volume":"3","author":"Kim","year":"2001","journal-title":"Neoplasia"},{"key":"key20180108122608_b23-etm-02-05-0887","first-page":"2104","article-title":"Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer","volume":"6","author":"Inoue","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20180108122608_b24-etm-02-05-0887","first-page":"415","article-title":"Role of endogenous tumor necrosis factor \u03b1 and interleukin 1 for experimental tumor growth and the development of cancer cachexia","volume":"51","author":"Gelin","year":"1991","journal-title":"Cancer Res"},{"key":"key20180108122608_b25-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1991.tb17252.x","article-title":"Interleukin-1 and tumor necrosis factor \u03b1 inhibit erythropoietin production in vitro","volume":"628","author":"Fandrey","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"key20180108122608_b26-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","article-title":"Interleukin-12: Biological properties and clinical application","volume":"13","author":"Del Vecchio","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180108122608_b27-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/156652305774964712","article-title":"Gene therapy of cancer based on interleukin 12","volume":"5","author":"Sangro","year":"2005","journal-title":"Currt Gene Ther"},{"key":"key20180108122608_b28-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1189\/jlb.0705358","article-title":"Interleukin-10 and the immune response against cancer: a counterpoint","volume":"78","author":"Mocellin","year":"2005","journal-title":"J Leukoc Biol"},{"key":"key20180108122608_b29-etm-02-05-0887","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.pcan.4500899","article-title":"Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomy","volume":"9","author":"Quatan","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2011.286\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T21:41:30Z","timestamp":1515447690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2011.286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,6,16]]},"published-print":{"date-parts":[[2011]]}},"alternative-id":["10.3892\/etm.2011.286"],"URL":"https:\/\/doi.org\/10.3892\/etm.2011.286","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}